Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single-dose liver disease agent vs placebo in healthy male subjects
jRCT2080224631Phase 1Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hepatic disease (2 arms), sponsored by EA Pharma Co., Ltd. Started Apr 2019; status: completed.
02
Conditions
hepatic disease
Beyond the preview
Go deeper on jRCT2080224631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224631.